Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency
Abstract. Dasatinib is an ABL1 tyrosine kinase inhibitor (TKI) with a short in vivo plasmatic half-life but with good efficiency, which is not fully understood. We investigated the possibility that circulating erythrocytes store and then provide dasatinib to target cells. In vitro coincubation of da...
Main Authors: | Kelly Airiau, Béatrice Turcq, Stéphane Bouchet, Elodie Laharanne, Jean-Philippe Vial, Gabriel Etienne, François-Xavier Mahon, Francis Belloc |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2018-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000041 |
Similar Items
-
Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01) -
Pharmacokinetics of Dasatinib
by: Jana Hořínková, et al.
Published: (2019-10-01) -
Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report
by: Shoko Ochiai, et al.
Published: (2019-03-01) -
Real-time analysis of imatinib- and dasatinib-induced effects on chronic myelogenous leukemia cell interaction with fibronectin.
by: Adam Obr, et al.
Published: (2014-01-01) -
Haemorrhagic Colitis Caused by Dasatinib
by: Nishant Patodi, et al.
Published: (2012-01-01)